Bharat Serums and Vaccines to invest Rs 200 crore in Genome Valley facility
"The Government of Telangana will extend all the support required by Bharat Serums and will also partner with BSV in areas like improving women's health," Rao said.
Hyderabad: Biopharmaceutical firm Bharat Serums and Vaccines Limited (BSV) on Tuesday said it would invest Rs 200 crore in the development of injectable and vaccine manufacturing facility at Genome Valley, India's first organised cluster for Life Sciences R&D and clean manufacturing activities.The facility will produce women health products, rabies vaccines, immunoglobulins, hormones,...
Hyderabad: Biopharmaceutical firm Bharat Serums and Vaccines Limited (BSV) on Tuesday said it would invest Rs 200 crore in the development of injectable and vaccine manufacturing facility at Genome Valley, India's first organised cluster for Life Sciences R&D and clean manufacturing activities.
The facility will produce women health products, rabies vaccines, immunoglobulins, hormones, among others.
Managing Director and Chief Executive Officer of Bharat Serums and Vaccines Limited Sanjiv Navangul met Telangana's Minister for Industry and Commerce KT Rama Rao to discuss the investment plan, according to a statement released by Bharat Serums and Vaccines Limited.
Read also: Bharat Serums gets DCGI nod to covid linked black fungus drug
"I and delighted to announce the entry of Bharat Serums in Genome Valley, Hyderabad. Telangana is known as the 'Vaccine Capital of the World' and Life Sciences capital of the Country. Entry of Bharat Serums Vaccines further highlights the strength of the life sciences sector in our state," Rao was quoted as saying in the press statement released by the company.
"The Government of Telangana will extend all the support required by Bharat Serums and will also partner with BSV in areas like improving women's health," the minister said.
Read also: Bharat Serums gets CDSCO panel nod to Recombinant Anti Rho-D Immunoglobulin Injection
Genome Valley was conceptualized in 1999 in Shamirpet, Hyderabad, India. It has India's largest concentration of multi-tenanted lab space in an organized cluster, and is emerging as the preferred destination for major Indian and global life sciences companies.
Genome Valley, spread over 600 sq kms in the vicinity of Hyderabad, is India's first systematically developed R&D cluster. The cluster synergizes a healthy mix of companies in the realm of agri-biotech, Clinical Research Management (CRM), biopharma, vaccine manufacturing, regulatory and testing, and other related areas.
Bharat Serums and Vaccines Limited is a Non-govt pharmaceutical company, incorporated in 1971.
Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement/treatment or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2024 Minerva Medical Treatment Pvt Ltd